Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ann H Partridge

Showing results (351-360 of 363) with videos related to

Pageof 37
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 29, 2026
Updated Results of the POSITIVE (Pregnancy Outcome and Safety of Interrupting Therapy for Women with Endocrine Responsive Breast Cancer) TrialOlivia Pagani, Samuel M Niman, Monica Ruggeri, et al.
Breast Cancer Research and Treatment|March 27, 2025
Impact of adding palbociclib on treatment adherence to ongoing adjuvant endocrine treatment in the global randomized PALLAS randomized trial in patients with early breast cancerEileen Shinn, David Zahrieh, Angela DeMichele, et al.
NPJ Breast Cancer|February 13, 2021
Clinical behavior and outcomes of breast cancer in young women with germline BRCA pathogenic variantsMatteo Lambertini, Marcello Ceppi, Anne-Sophie Hamy, et al.
The New England Journal of Medicine|May 3, 2023
Interrupting Endocrine Therapy to Attempt Pregnancy after Breast CancerAnn H Partridge, Samuel M Niman, Monica Ruggeri, et al.
Journal of the National Cancer Institute|July 7, 2025
Breastfeeding after breast cancer in young BRCA carriersEva Blondeaux, Virginia Delucchi, Elene Mariamidze, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 24, 2025
Clinical Behavior of Breast Cancer in Young <i>BRCA</i> Carriers and Prediagnostic Awareness of Germline <i>BRCA</i> StatusMatteo Lambertini, Eva Blondeaux, Loredana M Tomasello, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 15, 2020
Sensitive Detection of Minimal Residual Disease in Patients Treated for Early-Stage Breast CancerHeather A Parsons, Justin Rhoades, Sarah C Reed, et al.
The Lancet. Oncology|May 10, 2025
Association between risk-reducing surgeries and survival in young BRCA carriers with breast cancer: an international cohort studyEva Blondeaux, Amir Sonnenblick, Elisa Agostinetto, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 6, 2026
Radiation therapy management in BRCA1/2 carriers diagnosed with early breast cancer: An international cohort studyCarlotta Becherini, Eva Blondeaux, Virginia Delucchi, et al.
Breast Cancer Research and Treatment|June 13, 2021
Chemotherapy-related amenorrhea (CRA) after adjuvant ado-trastuzumab emtansine (T-DM1) compared to paclitaxel in combination with trastuzumab (TH) (TBCRC033: ATEMPT Trial)Kathryn J Ruddy, Yue Zheng, Nabihah Tayob, et al.
Pageof 37

Showing results (351-360 of 363) with videos related to

Sort By:
Pageof 37
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 29, 2026
Updated Results of the POSITIVE (Pregnancy Outcome and Safety of Interrupting Therapy for Women with Endocrine Responsive Breast Cancer) TrialOlivia Pagani, Samuel M Niman, Monica Ruggeri, et al.
Breast Cancer Research and Treatment|March 27, 2025
Impact of adding palbociclib on treatment adherence to ongoing adjuvant endocrine treatment in the global randomized PALLAS randomized trial in patients with early breast cancerEileen Shinn, David Zahrieh, Angela DeMichele, et al.
NPJ Breast Cancer|February 13, 2021
Clinical behavior and outcomes of breast cancer in young women with germline BRCA pathogenic variantsMatteo Lambertini, Marcello Ceppi, Anne-Sophie Hamy, et al.
The New England Journal of Medicine|May 3, 2023
Interrupting Endocrine Therapy to Attempt Pregnancy after Breast CancerAnn H Partridge, Samuel M Niman, Monica Ruggeri, et al.
Journal of the National Cancer Institute|July 7, 2025
Breastfeeding after breast cancer in young BRCA carriersEva Blondeaux, Virginia Delucchi, Elene Mariamidze, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 24, 2025
Clinical Behavior of Breast Cancer in Young <i>BRCA</i> Carriers and Prediagnostic Awareness of Germline <i>BRCA</i> StatusMatteo Lambertini, Eva Blondeaux, Loredana M Tomasello, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 15, 2020
Sensitive Detection of Minimal Residual Disease in Patients Treated for Early-Stage Breast CancerHeather A Parsons, Justin Rhoades, Sarah C Reed, et al.
The Lancet. Oncology|May 10, 2025
Association between risk-reducing surgeries and survival in young BRCA carriers with breast cancer: an international cohort studyEva Blondeaux, Amir Sonnenblick, Elisa Agostinetto, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 6, 2026
Radiation therapy management in BRCA1/2 carriers diagnosed with early breast cancer: An international cohort studyCarlotta Becherini, Eva Blondeaux, Virginia Delucchi, et al.
Breast Cancer Research and Treatment|June 13, 2021
Chemotherapy-related amenorrhea (CRA) after adjuvant ado-trastuzumab emtansine (T-DM1) compared to paclitaxel in combination with trastuzumab (TH) (TBCRC033: ATEMPT Trial)Kathryn J Ruddy, Yue Zheng, Nabihah Tayob, et al.
Pageof 37